The expression levels of PDCD1 , CTLA4 , and FCGR2B had a moderately significant prognostic power correlation in the PCR of trastuzumab-treated patients with breast cancer, those with AUC values of 0.619, 0.586, and 0.602, respectively ( Figure 4D ).
← all excerpts
Bioinformatics Analysis of Programmed Death-1-Trastuzumab Resistance Regulatory Networks in Breast Cancer Cells.
1
—
—